Join
Live feed
·
INSIDERFilingvia Quantisnow
Greenwich LifeSciences Inc. logo

VP Clinical Reg Affairs Thompson Jaye bought $16,000 worth of shares (1,000 units at $16.00), increasing direct ownership by 0.38% to 261,348 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GLSI· Greenwich LifeSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLSI (Greenwich LifeSciences Inc.) and more on Quantisnow.